| Insider Name | Buy/Sell | Company Name | Ticker | Amount | Shares Change | |||
|---|---|---|---|---|---|---|---|---|
| Mar 13, 2020 | Mar 17, 2020 | Oxtoby Andrew Chief Commercial Officer | Buy | Aimmune Therapeutics, Inc. | AIMT | $14.76 | $44,266 | +10.71% |
Sign in to view more
To unlock more features with more data and insights.
By continuing, you agree to our Terms of Service and Privacy Policy.